Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Samir Arbache is a Brazilian dermatology and medical technology entity founded by Dr. Samir Arbache, specializing in advanced drug delivery systems for skin conditions. The company is the pioneer of the Microinfusão de Medicamentos na Pele (MMP) technique, which uses a precision-controlled device to deliver medications directly into the dermal layer. This platform is extensively utilized for the treatment of androgenetic alopecia, melasma, and various forms of leukoderma. Beyond clinical practice, the entity functions as a research center and a training academy for dermatologists worldwide. Its innovations have significantly influenced the field of interventional dermatology and localized pharmacotherapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Samir Arbache.